Picture of Okta logo

OKTA Okta News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousLarge CapHigh Flyer

U.S. STOCKS ON THE MOVE-Abercrombie & Fitch, Boston Scientific, DoorDash

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

Wall Street was set for a subdued open on Wednesday after a sharp rally in the previous session, when cooling trade tensions boosted sentiment, as investors awaited AI leader Nvidia's results and minutes from the U.S. central bank's last meeting. .N

 ** Woodside Energy Group Ltd :

 BUZZ - Aussie energy stocks hit two-week high on stronger oil prices nL3N3S00AB

 ** Galaxy Digital Inc :
 BUZZ - Falls after stock offering launch nL6N3S00G6

 ** Azul SA :
 BUZZ - Plummets after filing for bankruptcy nL3N3S00Q0

 ** Okta Inc :
 BUZZ - Drops after maintaining annual revenue forecast, brokerages cut PT nL3N3S00OB

 ** Viking Holdings Ltd :
 BUZZ - Down after $1.3 bln secondary offering priced nL6N3S00HZ

 ** DoorDash Inc :
 BUZZ - Dips after upsized $2.5 bln convertible bond sale nL6N3S00HK

 ** Skechers USA Inc :
 BUZZ - TD Cowen downgrades Skechers to 'hold' after 3G Capital deal nL6N3S00HV

 ** Veru Inc :
 BUZZ - Rises as combo drug shows fewer side effects than semaglutide alone in trial nL3N3S00S5

 ** Gamestop Corp :
 BUZZ - Rises after it announces purchase of Bitcoin nL3N3S00TN

 ** Capri Holdings Ltd :
 BUZZ - Down after posting wider-than-expected quarterly loss nL6N3S00J4

 ** CenterPoint Energy Inc :
 BUZZ - Drops after $800 mln equity offering nL6N3S00J1

 ** Spero Therapeutics Inc :
 BUZZ - Soars as UTI drug trial with partner GSK stops after early success nL6N3S00JC

 ** Abercrombie & Fitch Co :
 BUZZ - Surges after Q1 results beat nL4N3612T0

 ** Boston Scientific Corp :
 BUZZ - Falls after discontinuing heart device, FDA approval pursuit nL3N3S00Y5

 (Compiled by Rajarshi Roy and Apratim Sarkar)

 ((Rajarshi.Roy@thomsonreuters.com))

Recent news on Okta

See all news